Millipore Expands BioPharma CRO Services in Europe
Advertisement
Millipore Corporation has moved its European BioPharma services unit to new, expanded facilities to accommodate strong growth in the biotechnology sector. The new facilities are located in Milton Park, near Didcot in Oxfordshire, England.
Millipore’s BioPharma Services unit is the first global contract research organization (CRO) dedicated exclusively to large molecule bioanalytical work. The unit arose from Millipore’s acquisition in August, 2009 of BioAnaLab, which specializes in the analysis of biopharmaceuticals and has been supporting drug development for the pharmaceutical industry for the past several years.
Geoff Hale, Managing Director of BioAnaLab said: “The new laboratory provides us with space to continue our growth as we expand the range of services we provide.” Craig Morley, Global Managing Director of Millipore’s BioPharma Services added: “"The new facility complements the outstanding facilities at our St. Charles site and is a significant milestone in our development as "The World's Large Molecule Lab."
Most read news
Organizations
Other news from the department manufacturing
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
EyeTechCare raises EUR 7.5 million in a second funding round and speeds up its development
David Evans steps down as chairman of the board for Horizon Discovery
New clinical and preclinical data on Basilea's novel antibiotic BAL30072 against multidrug-resistant Gram-negative superbugs
Parkinson’s researchers test a new approach against motor disorders
New virus drug will have to shoot at moving targets
New research may lead to improved diagnosis of autism
BioGaia initiates investigative study in type 2 diabetics
Viruses flourish in guts of healthy babies
Amorfix Life Sciences and Biogen Idec to collaborate on research for ALS disease